Integrative multi-omics approaches in cancer research: From biological networks to clinical subtypes

  • Yong Jin Heo
  • , Chanwoong Hwa
  • , Gang Hee Lee
  • , Jae Min Park
  • , Joon Yong An*
  • *Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Multi-omics approaches are novel frameworks that integrate multiple omics datasets generated from the same patients to better understand the molecular and clinical features of cancers. A wide range of emerging omics and multi-view clustering algorithms now provide unprecedented opportunities to further classify cancers into subtypes, improve the survival prediction and therapeutic outcome of these subtypes, and understand key pathophysiological processes through different molecular layers. In this review, we overview the concept and rationale of multi-omics approaches in cancer research. We also introduce recent advances in the development of multi-omics algorithms and integration methods for multiple-layered datasets from cancer patients. Finally, we summarize the latest findings from large-scale multi-omics studies of various cancers and their implications for patient subtyping and drug development.

    Original languageEnglish
    Pages (from-to)433-443
    Number of pages11
    JournalMolecules and cells
    Volume44
    Issue number7
    DOIs
    Publication statusPublished - 2021

    Bibliographical note

    Publisher Copyright:
    © The Korean Society for Molecular and Cellular Biology.

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • Cancer research
    • Genomics
    • Multi-omics approach
    • Proteogenomics
    • Proteomics
    • Systems biology

    ASJC Scopus subject areas

    • Molecular Biology
    • Cell Biology

    Fingerprint

    Dive into the research topics of 'Integrative multi-omics approaches in cancer research: From biological networks to clinical subtypes'. Together they form a unique fingerprint.

    Cite this